Neothetics Provides Business Update and Reports Second Quarter 2016 Financial Results
11 août 2016 08h00 HE
|
Neothetics, Inc.
SAN DIEGO, Aug. 11, 2016 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today provided a business update on its strategic and operational initiatives and reported financial results for the...
Neothetics Reports First Quarter 2016 Financial Results
12 mai 2016 08h00 HE
|
Neothetics, Inc.
SAN DIEGO, May 12, 2016 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today reported financial results and business progress for the first quarter 2016. First Quarter 2016 Highlights ...
Neothetics Announces Leadership Change and Preliminary Update on LIPO-202
18 févr. 2016 16h00 HE
|
Neothetics, Inc.
SAN DIEGO, Feb. 18, 2016 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced...
Neothetics Reports Fourth Quarter and Full Year 2014 Financial Results
26 mars 2015 08h00 HE
|
Neothetics, Inc.
SAN DIEGO, March 26, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today reported...
Lithera Announces Notice of Allowance for Key United States Patent Application for LIPO-202, Its Novel Product for Localized Fat Reduction
07 janv. 2013 09h00 HE
|
Neothetics
SAN DIEGO, Jan. 7, 2013 (GLOBE NEWSWIRE) -- Lithera, Inc. today announced receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for a patent application covering formulations and...
Lithera, Inc. Completes $20.6 Million Equity Financing
19 déc. 2012 09h00 HE
|
Neothetics
SAN DIEGO, Dec. 19, 2012 (GLOBE NEWSWIRE) -- Lithera, Inc. today announced investment of $20.6 million in preferred stock equity financing. Additional investment may provide the Company with up to a...